CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 4 Grant or award Director acquired 47,733 shares (grant or award)
- 4 Grant or award Director acquired 47,733 shares (grant or award)
- 4 Grant or award Director acquired 47,733 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 161,633 shares (grant or award)
- 4 Grant or award CHIEF INNOVATION OFFICER acquired 40,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 100,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 100,000 shares (grant or award)
- 4 Grant or award CHIEF INNOVATION OFFICER acquired 50,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 60,000 shares (grant or award)
- 4 Open-market buy Director bought 1,000 shares at $2.14 ($2,140)
- 4 Grant or award Chief Financial Officer acquired 26,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Innovation Officer acquired 17,000 shares (grant or award)
- 4 Grant or award Vice President of Innovation acquired 12,000 shares (grant or award)
- 4 Grant or award President and COO acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 44,000 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 11,521 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 11,521 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 16,374 shares (grant or award)
Page 2 of 12 · 234 filings